Correction: Dexmedetomidine induces immunogenic cancer cell death and sensitizes tumors to PD-1 blockade. BMJ Publishing Group.
Chicago Style (17th ed.) CitationCorrection: Dexmedetomidine Induces Immunogenic Cancer Cell Death and Sensitizes Tumors to PD-1 Blockade. BMJ Publishing Group.
MLA (9th ed.) CitationCorrection: Dexmedetomidine Induces Immunogenic Cancer Cell Death and Sensitizes Tumors to PD-1 Blockade. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.